Recruiting The STOP-MED CTRCD Trial NCT06183437 Conditions Antineoplastics Toxicity, Cancer, Cardiac Toxicity, +11 more Locations University of California, Los Angeles — Los Angeles, California, United States Brigham and Women's Hospital — Boston, Massachusetts, United States Baker Heart and Diabetes Institute — Melbourne, Victoria, Australia Cardio-Oncology Clinic, MAHI, University of Alberta Hospital — Edmonton, Alberta, Canada View all 14 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Immune Checkpoint Inhibitors Nephrotoxicity NCT04902846 Conditions Antineoplastics Toxicity, Disease, Kidney Injury, +3 more Locations Servicio de Oncología del CAUSA — Salamanca, Spain Servicio de oncología del Hospital Universitario de Valladolid — Valladolid, Spain View Trial Details
Active, Not Recruiting Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab NCT06237920 Conditions Antineoplastics Toxicity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more Locations Rijnstate — Arnhem, Gelderland, Netherlands Radboud University Medical Center — Nijmegen, Gelderland, Netherlands NKI-AVL — Amsterdam, North Holland, Netherlands Amsterdam UMC (AUMC) — Amsterdam, North Holland, Netherlands View more locations Show fewer locations Loading locations... View Trial Details
